Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-21-031390

EVP & Chief Tech Ops Officer sold 363 shares at $113.68 ($41,266)

From the SEC's structured data for this filing

Trades in this filing

Huang Dennis Karl · EVP & Chief Tech Ops Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-05-06 Sale : show line 1 in the form −363 $113.68 $41,266 40,506 D
Open-market sales · 363 sh · avg $113.68 · $41,266
Loading xslF345X03/doc4.xml…